✦ LIBER ✦

2027 ORAL Predictors of increased risk of breast fibrosis at 10 years with higher radiation dose in the early breast cancer (EORTC “Boost versus no Boost” trial 22881–10882).

✍ Scribed by S. Collette; L. Collette; T. Budiharto; J.C. Horiot; P. Poortmans; H. Struikmans; W.F. van den Bogaert; A. Fourquet; J.J. Jager; H. Bartelink

Book ID: 118625631
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 55 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)70789-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of the risk of fibrosis at 10

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

✍ Sandra Collette; Laurence Collette; Tom Budiharto; Jean-Claude Horiot; Philip M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 579 KB

Predictors of the risk of fibrosis at 10

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer - A study based on the EORTC trial 22881-10882 ‘boost versus no boost’

✍ DeFoe, S.G.; Jones, H.A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Erratum to ‘Predictors of the risk of fi

Erratum to ‘Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 “boost versus no boost” ’

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Impact of a Higher Radiation Dose on Loc

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881–10882 Trial

✍ Freedman, G.M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

O-113 Impact of a higher radiation dose

O-113 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the Randomized Boost Versus No Boost EORTC 22881–10882 Trial

✍ H. Struikmans; H. Bartelink; J.C. Horiot; P.M. Poortmans; W. Van den Bogaert; A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Impact of the boost dose of 10Gy versus

Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial

✍ Solin, L.J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 64 KB